Skip to main content
. 2022 Oct 17;12(10):2516. doi: 10.3390/diagnostics12102516

Figure 5.

Figure 5

Impact of Upk3b immunostaining on overall survival, recurrence-free survival, and cancer specific survival in muscle-invasive urothelial carcinomas.